EVP-6124 (Envivo) Clinical Trial

Guys,I am almost 100% sure I am gonna enter envivo’s evp-6124,it is said to improve clinical functioning and cognition memory…wish me well and pls reply if you wanna say something


Nice good luck man, How did you sign up? I so would if it was in my country.

Here is more information on their program:


Nicotine has been shown to enhance cognitive functions, such as learning, memory, and retention through the activation of nicotinic acetylcholine receptors in the brain. Alpha-7 nicotinic acetylcholine receptors are located in the areas of the brain that are important for cognition. EnVivo has developed a selective alpha-7 agonist program with compounds possessing cognitive-enhancing properties but that are also able to mediate the addictive properties and side effects of nicotine.

The lead compound in EnVivo’s alpha-7 agonist program, EVP-6124, is a selective, potent, brain penetrant oral compound that offers a novel mechanism of action - it enhances synaptic transmission in the brain and acts as a co-agonist in combination with Acetylcholine (ACh) to enhance cognition.

And more on their clinical trials programs:


And you can contact them here if you’re interested in joining their clnical trials program:


My doctor offered me this trial it’s available in US also,I from singapore

Cool, well please keep me and others on forum up to date with how it goes :smile:

if everyone from the forum joins doesnt that mean the medicine would only be effective against those most likely to seek out a forum